The RAD51-135C SNP modifies breast and ovarian cancer risk in BRCA2 carriers, but not in BRCA1 carriers.

被引：0
|
作者：
Levy-Lahad, E
Eisenberg, S
Dagan, E
Catane, R
Kaufman, B
Renbaum, P
Lahad, A
Gershoni-Baruch, R
机构：
[1] Shaare Zedek Med Ctr, Med Genet Unit, Jerusalem, Israel
[2] Rambam Med Ctr, Genet Inst, Haifa, Israel
[3] Shaare Zedek Med Ctr, Inst Oncol, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Dept Family Med, Jerusalem, Israel
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
252
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [41] Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    Satagopan, JM
    Boyd, J
    Kauff, ND
    Robson, M
    Scheuer, L
    Narod, S
    Offit, K
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3776 - 3781
  • [42] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [43] Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kim, Shana J.
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth Y.
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William D.
    Singer, Christian F.
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan L.
    Olopade, Olufunmilayo, I
    Eng, Charis
    Weitzel, Jeffrey N.
    Fruscio, Robert
    Narod, Steven A.
    Kotsopoulos, Joanne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2038 - 2043
  • [44] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [45] Ovarian cancer risk reduction after bilateral prophylactic oophorectomy (BPO) in BRCA1 and BRCA2 mutation carriers.
    Weber, BL
    Punzalan, C
    Eisen, A
    Lynch, HT
    Narod, SA
    Garber, JE
    Isaacs, C
    Daly, MB
    Neuhausen, SL
    Rebbeck, TR
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 59 - 59
  • [46] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [47] Differential ovarian cancer survival in Ashkenazi BRCA1/BRCA1 carriers.
    Levy-Lahad, E
    Kaufman, B
    Eisenberg, S
    Gottfeld, O
    Beller, U
    Renbaum, P
    Lahad, A
    Catane, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A135 - A135
  • [48] A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers
    Ding, Yuan C.
    McGuffog, Lesley
    Healey, Sue
    Friedman, Eitan
    Laitman, Yael
    Shani-Paluch-Shimon
    Kaufman, Bella
    Liljegren, Annelie
    Lindblom, Annika
    Olsson, Hakan
    Kristoffersson, Ulf
    Stenmark-Askmalm, Marie
    Melin, Beatrice
    Domchek, Susan M.
    Nathanson, Katherine L.
    Rebbeck, Timothy R.
    Jakubowska, Anna
    Lubinski, Jan
    Jaworska, Katarzyna
    Durda, Katarzyna
    Gronwald, Jacek
    Huzarski, Tomasz
    Cybulski, Cezary
    Byrski, Tomasz
    Osorio, Ana
    Ramony Cajal, Teresa
    Stavropoulou, Alexandra V.
    Benitez, Javier
    Hamann, Ute
    Rookus, Matti
    Aalfs, Cora M.
    de Lange, Judith L.
    Meijers-Heijboer, Hanne E. J.
    Oosterwijk, Jan C.
    van Asperen, Christi J.
    Garcia, Encarna B. Gomez
    Hoogerbrugge, Nicoline
    Jager, Agnes
    van der Luijt, Rob B.
    Easton, Douglas F.
    Peock, Susan
    Frost, Debra
    Ellis, Steve D.
    Platte, Radka
    Fineberg, Elena
    Evans, D. Gareth
    Lalloo, Fiona
    Izatt, Louise
    Eeles, Ros
    Adlard, Julian
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) : 1362 - 1370
  • [49] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [50] Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations
    Roukos, Dimitrios H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1555 - 1556
12345